HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Discovering and developing PI3 kinase inhibitors for cancer: rapid progress through academic-biotech-pharma interactions.

AuthorsFlorence I Raynaud, Paul Workman
JournalMolecular cancer therapeutics (Mol Cancer Ther) Vol. 10 Issue 11 Pg. 2017-8 (Nov 2011) ISSN: 1538-8514 [Electronic] United States
PMID22072803 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Comment)
Chemical References
  • Enzyme Inhibitors
  • Furans
  • Indazoles
  • Phosphoinositide-3 Kinase Inhibitors
  • Pyridines
  • Pyrimidines
  • Sulfonamides
  • Thiophenes
Topics
  • Animals
  • Enzyme Inhibitors (pharmacology)
  • Female
  • Furans (pharmacology)
  • Glioblastoma (drug therapy)
  • Humans
  • Indazoles (pharmacology)
  • Ovarian Neoplasms (drug therapy)
  • Phosphoinositide-3 Kinase Inhibitors
  • Pyridines (pharmacology)
  • Pyrimidines (administration & dosage, pharmacology)
  • Sulfonamides (pharmacology)
  • Thiophenes (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: